disease & medicine, microbiology

Autopsies recently carried out in California show that one person died of the disease on February 6—three weeks before the nation recorded its first fatality.

Assembling the first COVID-19 test kits in the same room as coronavirus material, along with other practices that didn’t follow protocol, made the tests unusable, officials say.

The University of Massachusetts Amherst is supplying local hospitals and the state with key ingredients needed for COVID-19 testing.

Vaporized hydrogen peroxide is the most effective decontamination method for masks that had been exposed to the coronavirus in a recent study.

President Donald Trump claims the World Health Organization failed to investigate early reports of the coronavirus, while public health experts argue that stripping the agency of its funding endangers us all.

Folding@Home, currently focused on deciphering the workings of SARS-CoV-2, is the first project to have exascale-level computational muscle.

The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.

As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.

An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.

Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.

School shutdowns might have a relatively small effect on preventing the transmission of SARS-CoV-2, a new meta-analysis suggests, though the preliminary data point to the need for more studies.

Several studies have indicated that SARS-CoV-2 might be spread through air, but not all experts are convinced.

Researchers report that dogs, pigs, chickens, and ducks did not easily become infected.

There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.

By infecting glioblastoma cells but not healthy brain tissue, some form of the virus could serve a therapeutic purpose.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  

The small number of genetic differences between the original strain of the novel coronavirus from Wuhan and those currently circulating in the US population indicates that a vaccine may likely offer lasting immunity.